製薬 × マーケットアクセス / プライシング / HEOR の求人情報一覧
-
NEW求人番号：Job-00268399 掲載日：2024-05-16
Access Strategy Senior Manager
Senior Manager position at global mega pharma1200 - 1800 万円 東京 製薬 マーケットアクセス / プライシング / HEOR
- 会社概要
- 同社は医療用医薬品を研究・開発・製造・販売しています。
- 業務内容
- Overview:Develop a compelling access strategy tailored for New Asset to stakeholder interests and needs and leads strategic & tactical planning for market access activities to ensure optimal patient access with appropriate price setting.
Drive a Local/Regional/Global cross-functional team to develop and implement access strategies for assigned assets.
Scrutinize the commercialization plan for the assigned asset from pricing &reimbursement perspectives
Obtain endorsements from TA Leads to implement access strategies.
Main Responsibilities:Develop and implement access plans for assigned assets, which include scenario-based pricing assumptions with strategic initiatives, secure patient access and identify opportunities for accelerating launch timing.
Investigate and build deep understandings of key stakeholders’ (payers, market access customers) needs and reflect these insights into business/access planning processes via leveraging real-world databases and information in the following areas: Epidemiology: Patient dynamics, pathology, genetic background, Diagnosis & treatment guidelines
Market Environment: Current market size, competitive landscape analysis
Physician/Patient/Payer Insights: Unmet medical needs, burden of Disease/QOL
Local/Overseas access environment: Policy, HTA/Reimbursement system
Lead discussions and presentations to senior management to get required funding for launch optimization projects, including HEOR, HTA, RWD based data generation, as well as unbranded campaigns, etc., identified through cross functional discussion.
Work in close alignment and cooperation with a cross-section of colleagues (Global Access & Value, Global Commercial Development, Global Medicine Team, MA, DJ, Business Unit, A&V, P&PA, and BAI) through JMT/JVT/JAT.
Participate in JDC/J-PRC for portfolio entry, Global DP3 and Japan buy-up etc. through asset assessment in related TA as required.
Develop and include value claims for the brand at NDA to support optimal access.
Support NAA on developing reasonably accurate Long-rage revenue/expense/demand forecast for company pipeline assets and BD projects until 18 months prior to approval.
Support NAA on developing data, insights and recommendations for Strategic Plans that include strategies, tactics, and programs to maximize the long-term potential of development compounds, and obtain senior management endorsement.
Yui Osone
Pharma -
NEW求人番号：Job-00266089 掲載日：2024-05-15
Pricing & External Affairs Senior Manager
Pricing Senior Manager position at global mega pharma1200 - 1800 万円 東京 製薬 マーケットアクセス / プライシング / HEOR
- 会社概要
- 同社は医療用医薬品を研究・開発・製造・販売しています。
- 業務内容
- ResponsibilitiesDevelop strategic NHI pricing strategies and gain endorsement of NHI pricing strategies and proposals of NHI prices with Country President and TA Leads through the Pricing Committee
Develop robust pricing dossiers and strategically manage price negotiations
Build strong alignment & partnership among Japan Pricing Core members (New Asset & Access Strategy team, New Asset Analysis team, DJ, Medical, Launch Excellence Team, Policy and Public Affairs, and the global PHI) to ensure optimal price setting
Develop Pricing-related OP assumptions
Refresh pricing assumptions and estimated prices for pipeline products and BD assets to reflect the latest competitive environment
Minimize the downward price adjustment by price revision/repricing through cross-functional collaboration
Maintain good relationship with “Policy Planning Division for Pharmaceutical Industry Promotion and Medical Information Management, MHLW” (former EAD) and act as a mediator between the company and MHLW to flawlessly manage all product-related issues, as well as NHI pricing negotiation
Actively participate in trade association activities (FPMAJ, PhRMA, FIRM, etc.) to establish a pro-innovative pricing framework
Contribute to building a high performing team by actively engaging in coaching junior colleagues and nurturing a positive environment where people feel energized and eager to speak up
Yui Osone
Pharma -
求人番号：Job-00208211 掲載日：2024-05-10
Analyst
Analyst600 - 1000 万円 東京 製薬 マーケットアクセス / プライシング / HEOR
- 会社概要
- This is the exclusive business partner and adviser to biopharma senior management teams
- 業務内容
- Demonstrated ability to be an important contact for the client in all communications
Ability to present independently to the client
Demonstrates strong understanding of assets that best fit the client
Ability to interact with partners and manage diligence requests
Able to trouble shoot assessment to evaluate target niches
Basic understanding of financial analysis and modelling, including DCF models and comparable transactions
Ability to author thought leadership pieces
Provide support in quality control and in ensuring the product is polished for Associate review
Having experience and understanding of the health care industry
Martin Tsvetkov
Pharma -
求人番号：Job-00257819 掲載日：2024-05-10
マーケットアクセス担当者
新薬収載手続き経験者必見です!800 - 1300 万円 東京 製薬 マーケットアクセス / プライシング / HEOR
- 会社概要
- 同社は、医薬品の研究、開発、製造、販売および輸出を行っています。
- 業務内容
- 製品チームに所属して頂き、社内外のマルチステークホルダーとコミュニケーションを密に取りながら、価格・アクセス戦略を推進して頂く役割です。
（以下は例示） 製品担当：担当製品の価格・アクセス戦略の検討・推進
薬価等実務：新薬や既収載薬、医療機器の価格・保険適用手続き全般など
Patrick Chang
Pharma -
求人番号：Job-00267191 掲載日：2024-05-07
Director: RWE Partnerships & Innovation
Director position at global mega pharma1600 - 3000 万円 東京 製薬 マーケットアクセス / プライシング / HEOR
- 会社概要
- 同社は医療用医薬品を研究・開発・製造・販売しています。
- 業務内容
- The RWE Partnerships and Platforms organization functions to:Enhance company's ability to determine unmet medical needs;
Support differentiated product labels for Product Development programs including finding alternatives and accelerated licensure pathways for new indications through the use of Real World Data (RWD), Real World Insights (RWI) and Real World Evidence (RWE);
Inform clinical practice on appropriate prescription and use of company products;
In collaboration with Access & Value, strengthen the value evidence package for payers and access/policy decision-makers;
Support measurement of short- and long-term impact of company products to both patients and populations;
Support competitive differentiation.
This position will serve as the Real World Data point of contact for either one category or one geographic region.Execute on prioritized tactical plans with actionable projects, identify external partners to deliver strategic RWE capabilities / data, and oversight of high quality methods and designs to inform study / project designs for R&D franchise / asset teams, CMAO, Health Economics and Outcomes Research, Commercial and other functions’ needs
Provide daily mentorship, motivation, and guidance to more junior RWE colleagues, & direct them to co-develop emerging, core a strategic partnerships with commercial and academic data suppliers
Supports landscape assessments, new data / tool / partner due diligence assessments based on understanding evolving healthcare, technology and other industries with Customers, RWE Digital platform team, Digital RWD Enterprise Enabling Platform, RWE Biostatistics and other relevant partners
Documents all requests and track progress toward project completion, other metrics and business goals
Develops training materials for ensuring colleagues understanding and competency in various aspects of the RWE process
Communicates critical knowledge on business processes to relevant stakeholders
Yui Osone
Pharma -
求人番号：Job-00265956 掲載日：2024-03-25
【ヘルスケア業界】マーケットアクセス・薬価戦略担当リサーチマネージャー
統計解析の経験をお持ちの方必見です!550 - 800 万円 東京 製薬 マーケットアクセス / プライシング / HEOR
- 会社概要
- 同社はマーケティングリサーチ会社の日本支社です。
- 業務内容
- 日本/海外の製薬会社・医療機器メーカーに対して:
マーケットアクセス・薬価戦略に関するコンサルティングおよび調査プロジェクトの企画・推進・監督
APACおよび日本の上長に報告・連携を取りながら、キーアカウントプランの作成と実行
クライアントの意思決定を支援し、信頼関係の構築
日本における、マーケットアクセス・薬価戦略の調査・コンサルティング業務のビジネス拡大
具体的な業務内容:
クライアントから依頼を受け、調査企画書・見積の作成
デスクリサーチの設計・実施
ディスカッションガイドの作成、およびペイヤー、医師、患者支援団体等へのインタビュー等の実施・監督
収集したデータ・情報の分析、調査結果に基づく明確で実行性のある提案
マーケットアクセス部門の人材獲得・育成
その他、ヘルスチーム上長から指示された業務
Patrick Chang
Pharma
1